Certified by Founder Lodge
Redmile Group
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $150,000,000
25 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Redmile Group is a company based out of San Francisco.
| Company | Date | Round | Raised |
|---|---|---|---|
Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
Saluda Medical |
April, 17 ,2023 | Unknown | $150,000,000 |
ElevateBio |
May, 25 ,2023 | Series D | $401,000,000 |
Orbital Therapeutics |
April, 27 ,2023 | Series A | $270,000,000 |
ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
Boundless Bio |
May, 17 ,2023 | Series C | $100,000,000 |
Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
ElevateBio |
May, 25 ,2023 | Series D | $401,000,000 |
Star Therapeutics |
September, 05 ,2023 | Series C | $90,000,000 |
ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
Abcuro, Inc |
August, 18 ,2023 | Series B | $155,000,000 |
GRO Biosciences |
July, 23 ,2024 | Series B | $60,300,000 |
Star Therapeutics |
September, 05 ,2023 | Series C | $90,000,000 |
Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
Clear Labs |
January, 14 ,2025 | Series D | Undisclosed Amount |
GRO Biosciences |
July, 23 ,2024 | Series B | $60,300,000 |
Neuron23 |
June, 26 ,2025 | Series D | $96,500,000 |
Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
One Biosciences |
July, 17 ,2025 | Series A | $17,382,375 |
Clear Labs |
January, 14 ,2025 | Series D | Undisclosed Amount |
Neuron23 |
June, 26 ,2025 | Series D | $96,500,000 |
One Biosciences |
July, 17 ,2025 | Series A | $17,382,375 |
Electra Therapeutics |
October, 22 ,2025 | Series C | $183,000,000 |
Boundless Bio
Saluda Medical
ElevateBio
Orbital Therapeutics
ADARx Pharmaceuticals Inc.
Abcuro, Inc
Star Therapeutics
Attovia Therapeutics
GRO Biosciences
Candid Therapeutics
Clear Labs
Neuron23
One Biosciences
Electra Therapeutics
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)